Relay Therapeutics Inc


Relay Therapeutics Inc

Health CarePharmaceuticals and Biotechnology
  • Price (USD)11.08
  • Today's Change-0.06 / -0.54%
  • Shares traded522.04k
  • 1 Year change-31.35%
  • Beta--
Data delayed at least 15 minutes, as of Jun 01 2023 19:43 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
Equities ScreenerGo to the Equities Screener

Events & Activity

  • RLAY:NMQ price moved over -4.36% to 10.52
  • RLAY:NMQ price falls below 15-day moving average to 10.73 at 10:41 BST
  • RLAY:NMQ price falls below 15-day moving average to 10.52 at 10:30 BST

Key statistics

As of last trade, Relay Therapeutics Inc (RLAY:NMQ) traded at 11.08, 14.58% above the 52 week low of 9.67 set on May 16, 2023.
52-week range
9.67May 16 202333.06Sep 08 2022
Short selling activity
Provided by S&P Global Market Intelligence
Previous close11.14
Average volume1.41m
Shares outstanding121.61m
Free float118.14m
P/E (TTM)--
Market cap1.35bn USD
EPS (TTM)-2.80
Data delayed at least 15 minutes, as of Jun 01 2023 19:43 BST.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.